Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease.
about
Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunityCytokine and Chemokine Profile in Amicrobial Pustulosis of the Folds: Evidence for AutoinflammationCommon Polymorphisms in IFI16 and AIM2 Genes Are Associated With Periodontal Disease.Inflammasomes and intestinal inflammation.Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy.Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.Inflammasomes in the Gut Mucosal Homeostasis.Transcriptomic Landscape of Treatment - Naïve Ulcerative Colitis.The AIM2 inflammasome: Sensor of pathogens and cellular perturbations.Regulation and Sensing of Inflammasomes and Their Impact on Intestinal Health.Integrated strategy of differentially expressed genes associated with ulcerative colitis.Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease.Malignant peritoneal mesothelioma and Crohn disease.Enteric Virome Sensing-Its Role in Intestinal Homeostasis and Immunity.Roseburia intestinalis inhibits interleukin‑17 excretion and promotes regulatory T cells differentiation in colitis.The Absent in Melanoma 2-Like Receptor IFN-Inducible Protein 16 as an Inflammasome Regulator in Systemic Lupus Erythematosus: The Dark Side of Sensing Microbes.IFI16 filament formation in salivary epithelial cells shapes the anti-IFI16 immune response in Sjögren's syndrome
P2860
Q33613121-3FB9D481-ACD8-4EB6-A5A3-BAE369E3EFD8Q36592682-C7866759-64C8-4876-84A7-DAA0B44D0A56Q37328410-043F0F0A-08BB-4C1C-9E24-4A82FFCCF44CQ38848308-DE0FEC3D-C691-4065-9856-12BB76D67788Q39237282-DEFE99F2-63DD-4C22-925C-B406F45CF5B2Q40578397-E342BEA3-8132-46F8-92C9-422246199113Q41846031-A45E1B34-69FA-4216-A9B7-D6C7A44BCFFEQ41935570-C2461122-E926-4DC0-BA4C-BEE136E24FC9Q42778188-21047049-B9C3-42EF-B288-9C35765EDA5DQ46238323-F3695A4F-056C-4320-959D-6B6113EEAA12Q47146914-4B9923E3-1CF6-4FBE-BB85-F3F44C799C81Q47749878-5163FFD9-0ED4-4134-8DD5-4D6C4C041166Q47835525-E30D359A-FD03-409F-9037-0EFCD653E5D2Q53057723-87F4A80E-A3F1-4F59-AD06-27B6E5E13F95Q54249868-543A7215-11F5-4CFE-A908-ACE5D79A37EAQ55128199-DEF63555-C6D3-487B-AB4F-A5F61B877064Q55436021-DA07797E-6355-49BD-93A0-09EAD022CED6Q59125538-A1D40888-245F-42CD-B15D-8FFFC27BE5B2
P2860
Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Strong Upregulation of AIM2 an ...... ve Inflammatory Bowel Disease.
@en
Strong Upregulation of AIM2 an ...... ve Inflammatory Bowel Disease.
@nl
type
label
Strong Upregulation of AIM2 an ...... ve Inflammatory Bowel Disease.
@en
Strong Upregulation of AIM2 an ...... ve Inflammatory Bowel Disease.
@nl
prefLabel
Strong Upregulation of AIM2 an ...... ve Inflammatory Bowel Disease.
@en
Strong Upregulation of AIM2 an ...... ve Inflammatory Bowel Disease.
@nl
P2093
P2860
P50
P1476
Strong Upregulation of AIM2 an ...... ve Inflammatory Bowel Disease.
@en
P2093
Anica Schraenen
Dominiek Staelens
Frans Schuit
Gert De Hertogh
Ingrid Arijs
Isabelle Cleynen
Jan Van der Goten
Leentje Van Lommel
Marc Ferrante
P2860
P304
P356
10.1097/MIB.0000000000000535
P577
2015-08-06T00:00:00Z